The Coca-Cola Company (KO): JPMorgan remains Overweight on Coca-Cola, citing durable growth, pricing power and improving U.S. trends

Overview

This event-feedback report reiterates JPMorgan's constructive view on Coca-Cola following European investor meetings and the JPMorgan All-Stars Conference. The institution sees a balanced combination of volume and pricing-led growth, supported by brand strength, global reach and an asset-light structure, while recognizing the IRS dispute, uneven consumer conditions and inflation-related risks.

Core views

JPMorgan maintains an Overweight rating on Coca-Cola and believes the company can deliver sustainable organic growth toward the upper end of its long-term 4–6% range. Its thesis rests on portfolio improvements, global refranchising and bottler consolidation, upgraded U.S. systems and procurement, a shift from volume toward value growth, and management transition. The institution characterizes KO as an asset-light brand owner that can compound through a balanced mix of volume and pricing while being less directly exposed to commodity-cost shocks than more asset-intensive peers. The report acknowledges that the latest 5% global volume growth was exceptional—the strongest comparable performance in 17 quarters—and that the bar to meet the raised approximately 5% organic-sales-growth guidance is low because strong first-half growth, FIFA-related demand, favorable European weather and six fewer selling days in 4Q create an expected deceleration. Nevertheless, JPMorgan sees the underlying growth algorithm as durable. About 84% of unit-case volumes are outside the U.S., where much of the population in developing and emerging markets still consumes non-commercial beverages and Coca-Cola's share is about 6%, versus about 14% in developed markets. The report argues that zero-sugar and zero-calorie offerings can support sparkling-beverage share gains, while premium innovation in developed markets and volume expansion in emerging markets can sustain the 4–6% organic-growth framework even if full-sugar Coca-Cola is flat to declining in mature markets. Pricing and package architecture are central to the thesis. Historically, roughly half of Coca-Cola's 4–6% organic-growth algorithm has come from volume and the remainder from price/mix. As a master franchisor, the company has limited direct commodity exposure aside from inputs such as sugar, coffee, tea and juice, though bottlers still face aluminum, PET and transportation costs. JPMorgan expects pricing to run modestly ahead of inflation through more accretive packaging, partly offset by a geographic mix headwind as faster-growing emerging markets have lower revenue per case. Management's emphasis on affordable packs across income levels is presented as important for maintaining demand while implementing price increases. Growth initiatives reinforce this view. Fairlife is running at approximately 25–30% growth and generates about $4 billion of annual retail sales. A $650 million Webster, New York facility is already producing commercially, while a further $600 million Coopersville, Michigan expansion is expected to be completed in 2028; together, the projects are intended to more than double supply and broaden SKU and flavor availability. In U.S. tracked channels for the L10W ended 6 September 2026, Fairlife grew 26.1%, with milk up 22.6% and shakes up 27.9%; JPMorgan notes that the acceleration also benefited from easier comparisons, as two-year stacked growth eased to 42.8% from 44.5%. The report also describes the European relaunch of Coca-Cola Zero Sugar Zero Caffeine as successful, with expansion announced for Brazil, Mexico and Chile and an expected, but not announced, U.S. rollout at some point in early 2027. Recent U.S. data support the near-term earnings view. In Circana MULO+C tracked channels, total KO dollar and unit takeaway grew 6.8% and 1.9%, respectively, in the L10W ended 6 September, accelerating from 5.6% and 0.4% in the L13W ended 28 June. Carbonated soft-drink sales grew 6.5%, driven by 4.9% volume and 1.6% price/mix, while Coca-Cola gained 113 bps of dollar share and 137 bps of volume share year on year. The report expects 3Q26 EPS of $0.89, versus Bloomberg consensus of $0.88, and organic sales growth of 4.5%, versus Consensus Metrix at 4.2%. Its unit-case-volume estimate is 2.8%, broadly in line with consensus at 2.7%, while its 2.6% price/mix forecast is slightly above consensus at 2.3%. JPMorgan leaves its FY26 estimates unchanged and expects a 32.2% EBIT margin, 36 bps below consensus, partly reflecting the possibility that some estimates include CCBA sales late in 3Q26. The IRS tax dispute remains an overhang but does not alter JPMorgan's investment view. The hearing is expected within 12–18 months. Coca-Cola has deposited $6 billion in escrow and, in the stated worst case, could owe another $14 billion in potential past tax liabilities; the report also identifies a possible approximately 250 bps increase in the marginal tax rate to 22–23% as the larger perpetuity impact. JPMorgan notes the favorable 3M outcome as a relevant precedent and argues that Coca-Cola's approximately $12.4 billion of free cash flow and leverage of about 1.6x, versus a 2.5x target, leave it able to continue investment and M&A despite the case. JPMorgan lowers its Dec-2027 target price to $95 from $96, while retaining Overweight. The valuation uses 24.9x P/E, in line with KO's current CY2027 multiple, applied to the institution's CY2028 EPS estimate of $3.81. The $95 target implies approximately 8% upside over roughly 15 months plus an approximately 2.5% dividend yield. The report argues that best-in-class volumes, inflation pass-through and defensive characteristics should preserve a relative valuation premium and offset concerns over GLP-1 drugs and tax liabilities, which it believes are already reflected in the valuation.

Analysis framework

JPMorgan combines management-meeting feedback with operating data, tracked-channel data, quarterly estimates versus consensus, long-term volume and pricing drivers, capital-allocation analysis and a P/E-based target-price framework. It assesses whether global demand, price/mix, brand and capacity initiatives can sustain Coca-Cola's organic-growth algorithm, then weighs tax, inflation and demand risks against cash generation and leverage.

Methodology notes

• Industry AnalysisVolume-price decomposition

  Organic sales growth is analyzed through unit-case volume and price/mix.

  The report argues that Coca-Cola's long-term growth algorithm is supported by roughly equal contributions from volume and price/mix, while highlighting geographic mix as a partial offset.

• Valuation methodsP/E and PEG Valuation

  Target price based on a forward P/E multiple applied to CY2028 EPS.

  JPMorgan applies 24.9x P/E to its $3.81 CY2028 EPS estimate to derive the $95 Dec-2027 target price.

• Corporate Fundamentals and FinanceFree cash flow analysis

  Free cash flow and leverage are used to assess resilience to the tax dispute and capacity for investment or M&A.

  The report cites approximately $12.4 billion of free cash flow and leverage of about 1.6x against a 2.5x target to argue that the tax case should not constrain capital allocation.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• The Coca-Cola Company (KO)

  Primary covered company; JPMorgan sees durable volume-plus-pricing growth and favorable risk/reward.

  Strengths

  Global brand equity, market-share momentum, asset-light model, pricing power, diversified geographic exposure, Fairlife growth and robust free cash flow.

  Weaknesses

  Growth is expected to decelerate after unusually strong first-half conditions, and emerging-market mix can pressure revenue per case.

  Comparison

  KO's approximate 6% share in developing and emerging markets is below its approximately 14% share in developed markets, leaving runway for share gains.

  Risks

  Economic weakness, GLP-1-related demand uncertainty, inflation-driven margin pressure, volume losses, ingredient or formulation concerns, unfavorable FX and tax liabilities.

• Monster Beverage (MNST)

  JPMorgan views the appointment of its former Americas CEO as positive for KO and negative for MNST.

  Weaknesses

  Loss of its former Americas CEO to Coca-Cola's North America operating unit.

Key data

• 3Q26E EPS$0.89JPMorgan estimate, 1.5% above Bloomberg consensus of $0.88
• 3Q26E organic sales growth4.5%30 bps above Consensus Metrix consensus of 4.2%
• U.S. tracked-channel dollar takeaway+6.8%L10W ended 6 Sep 2026, accelerating 120 bps from +5.6% in L13W ended 28 Jun 2026
• Coca-Cola CSD sales growth+6.5%L10W ended 6 Sep 2026; driven by +4.9% volume and +1.6% price/mix
• Fairlife growth+26.1%L10W ended 6 Sep 2026; milk grew 22.6% and shakes 27.9%
• IRS escrow deposit$6 billionThe report states a worst-case additional past-tax liability of $14 billion
• CY2028E EPS$3.81Used with a 24.9x P/E multiple for the $95 target price

Impact & implications

JPMorgan believes Coca-Cola's global distribution, zero-sugar innovation, pricing architecture and Fairlife capacity additions can support a premium valuation despite a more uneven consumer environment. The institution views the tax case as an overhang rather than a constraint on investment or M&A because of the company's cash generation and below-target leverage.

Risks

• Economic weakness could create material pressure in Coca-Cola's away-from-home channel.
• Potential longer-term effects of GLP-1 drugs could weigh on demand.
• Inflationary costs or volume losses could cause margin deleverage.
• Ingredient or formulation concerns could impair demand or earnings.
• Volatile or unfavorable foreign-exchange movements outside hedged currencies could drive negative earnings revisions.

What to watch

• The 3Q26 result, including whether organic sales growth reaches JPMorgan's 4.5% estimate and EPS reaches $0.89.
• Sustainability of volume and market-share momentum after FIFA and favorable European-weather benefits fade.
• Fairlife capacity ramp-up at Webster and progress on the Coopersville expansion expected to complete in 2028.
• Potential early-2027 U.S. rollout of Coca-Cola Zero Sugar Zero Caffeine.
• Timing and outcome of the IRS tax-case hearing expected within 12–18 months.